Uncategorized
WK Kellogg Q4: EPS Beat, Sales Miss Amid Challenging Market Conditions
WK Kellogg reported fourth-quarter adjusted EPS of 42 cents, beating the street view of 26 cents. Quarterly sales of $640 million (down 1.8%) missed the analyst consensus estimate. read more
Novartis To Beef Up Heart Disease Offering With $3 Billion Blackstone-Backed Anthos Therapeutics Deal
Novartis is acquiring Anthos Therapeutics for up to $3.08 billion, adding abelacimab, a late-stage anticoagulant, to its cardiovascular portfolio. read more
Marriott Tops Q4 Estimates As 2025 Outlook Pressures Stock
Marriott’s lower FY25 outlook led to a decline in share prices. The company anticipates 2%-4% RevPAR growth for FY25. read more
Nano Cap Lipella Pharmaceuticals Stock Jumps On Positive Trial Data In Patients With Sore Mouth Membranes
Lipella’s LP-310 Phase 2a trial showed strong efficacy and safety for oral lichen planus. The company plans a Phase 2b trial and an FDA designation request in 2025. read more
Hesai’s Lidar Takes On Bigger Role In BYD’s ‘God’s Eye’ Advanced Driver Assistance
Hesai Technology entered into an enhanced collaboration with Chinese EV maker BYD Co., with plans to supply lidar for BYD’s models. read more
SMCI Stock Bullish Ahead Of Q2 Earnings, But 25% Downside Looms, Analysts Warn
SMCI will report Q2 earnings, with EPS expected at 75 cents and revenues at $6.13B. Stock down 44.83% YoY, up 41.93% YTD. Analysts see 25% downside with a price target of $30.33. read more
AMD Expands AI Research With CEA Partnership, Aiming for Energy-Efficient Computing
AMD collaborates with CEA to develop energy-efficient AI systems and advance next-gen computing infrastructure. read more